Company Filing History:
Years Active: 2024
Title: Mikko Mäkelä: Innovator in Cytochrome P450 Research
Introduction
Mikko Mäkelä is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit cytochrome P450 monooxygenase 11A1.
Latest Patents
Mäkelä holds a patent for "Pyran derivatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors - Compounds of formula (I)." This innovation represents a step forward in the search for effective inhibitors that could have various applications in medicine.
Career Highlights
Throughout his career, Mikko has worked with prominent companies such as Orion Corporation and Helvar Oy Ab. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.
Collaborations
Mäkelä has collaborated with notable individuals in his field, including David Din Belle and Mikko Passiniemi. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Mikko Mäkelä's work in the field of cytochrome P450 research exemplifies the impact of innovative thinking in science. His contributions continue to influence the development of new therapeutic compounds.